Ligand Pharma (LGND) Pursuing Plans for OmniAb to Become a Standalone Public Company

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. META
4. SPY
5. FDX
6. IBM
7. MU
8. ACN
9. USO
10. NVDA

Go back to Ligand Pharma (LGND) Pursuing Plans for OmniAb to Become a Standalone Public Company
LIGAND PHARMA (NASDAQ: LGND) Delayed: 279.44 +17.27 (6.59%)
Previous Close $262.17    52 Week High $139.79 
Open $259.35    52 Week Low $82.07 
Day High $282.53    P/E 649.86 
Day Low $258.00    EPS $0.43 
Volume 2,347,177